After 2 hours, islets were subjected to either liraglutide (100 nM) (107, 108) or saline treatment for 12 hours (DART-Seq) (8, 85, 109) in order to assess changes in RNA expression or 24 hours (7, 85, 107) (IHC, active GLP-1 measurements) in order to assess changes in protein content, as previously validated (85)
But this is where caution matters
Robert Popovian 11:44 Well, expanding access, definitely, weve seen this right
Through technology transfer, Daewoong Pharmaceutical plans to begin phase 1 clinical trials in early 2024
Understanding your peptide pathway genetics allows you and your provider to weigh berberine's gentler, slower metabolic effects against GLP-1 agonism's rapid appetite and insulin regulation
To learn more about youtheory and its offerings, please visit www.youtheory.com and follow along on social media @youtheory